Promising patient studies surrounding Retatrutide , specifically the 120 milligram formulation ZPHC ZPHC, reveal a significant impact on physique loss and related metabolic conditions . Researchers anticipate that this dual retatrutide zphc 120mg acting , targeting both GLP-1 and GIP pathways , could represent a substantial improvement in the appr